Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Oct 7 · above the Ichimoku cloud · RSI 55 · MACD above its signal
| 1.90 | Previous month high | +48.44% |
| 1.90 | 52-week high | +48.44% |
| 1.28 | Price now | |
| 1.28 | R3 (classic) | −0.00% |
| 1.28 | R2 (classic) | −0.00% |
| 1.28 | R1 (classic) | −0.00% |
| 1.28 | Pivot | −0.00% |
| 1.28 | S1 (classic) | −0.00% |
| 1.28 | S2 (classic) | −0.00% |
| 1.28 | S3 (classic) | −0.00% |
| 1.28 | Previous day high | −0.00% |
| 1.28 | Previous day low | −0.00% |
| 1.28 | Previous week high | −0.00% |
| 0.8000 | Previous month low | −37.50% |
| 0.3000 | Previous week low | −76.56% |
| 0.0200 | 52-week low | −98.44% |
None of the 29 investors followed here reported a position in SONX in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SONX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -56.7 | 30.8 | 194.1 | 0.0 | -34.0 | 81.8 | 68.3 | 18.8 | -33.3 | 60.0 | +326.7% | ||
| 2025 | 29.8 | -19.6 | -27.0 | -17.4 | 16.7 | -13.5 | -98.1 | 36.4 | 900.0 | -13.3 | 0.0 | 15.4 | −83.4% |
| 2024 | -25.9 | 15.4 | -41.0 | -11.7 | -8.3 | -20.7 | 8.5 | -12.1 | -33.6 | -0.2 | -63.4 | -42.5 | −95.7% |
| 2023 | -7.4 | -4.6 | -20.0 | -10.0 | -29.4 | 7.1 | -5.1 | -24.0 | -23.9 | -65.8 | -45.8 | 52.2 | −92.6% |
| 2022 | 25.2 | -33.4 | -16.5 | -30.9 | 0.7 | -38.4 | 5.8 | -34.6 | -10.1 | 66.4 | 34.3 | 18.4 | −50.9% |
| 2021 | 5.4 | -40.6 | −37.4% |
No insider transactions reported for SONX.
No analyst coverage for this instrument.
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for endodontists. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.